Company: GMRE
Filing Date: 2025-03-31
Form Type: DEF 14A
Source: 0001104659-25-029872
Chunk: 13

Company: Global Medical REIT Inc.
Filing Date: 2025-03-31
Form: DEF 14A
Chunk 13
---
 from 3.83% as of December 31, 2023 to 3.75% as of December 31, 2024. Although the Company’s cost of indebtedness decreased during the year, its cost of equity increased due to a decrease in the price of the Company’s common stock, which decreased from $11.10 as of December 29, 2023 (the last trading day in 2023) to $7.72 as of December 31, 2024. Asset Acquisitions Despite the Company’s cost of capital challenges in 2024, it was able to purchase and place under contract to purchase an aggregate of $150 million of healthcare facilities, consisting of:

| ● | a                                                                                             
 portfolio of 15 healthcare facilities for an aggregate purchase price of $80.3 million, which 
 closed during 2024; and                                                                       |

| ● | a                                                                                           
 portfolio of five healthcare facilities for an aggregate purchase price of $69.6 million,   
 which the Company entered into a contract to acquire during the fourth quarter of 2024 (the 
 “Five-Property Portfolio”). The Company completed the acquisition of three properties       
 in the Five-Property Portfolio in February 2025.                                            |

The Company believes the acquisition of these two portfolios demonstrates its ability to source accretive, high-quality deals despite its elevated cost of capital. The Company’s obligations to close on the remaining two properties in the Five-Property Portfolio are subject to certain customary terms and conditions. Accordingly, there is no assurance that the Company will close the remainder of this acquisition on a timely basis, or at all. Sustainability and Human Capital Resources Our business values integrate environmental sustainability, social responsibility, and strong governance practices throughout our Company. Our Board’s approach to these practices is viewed through the lens of reducing and controlling the Company’s risk profile. Our Board continues to lead our sustainability efforts, and our Board has a standing committee focused on such efforts. The primary purpose of this committee is to assist the Board in fulfilling our responsibilities to provide oversight and support of our efforts and goals regarding sustainability matters by overseeing: (1) our general sustainability strategy and policies as set by our management, (2) communications with our employees, investors, and other stakeholders with respect to sustainability matters, (3) developments relating to, and improving our understanding of, sustainability matters, (4) our compliance with certain sustainability-related legal and regulatory requirements, and (5) coordination with other Board committees on sustainability matters of common import. In June 202